Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study.

Saved in:
Bibliographic Details
Title: Outcomes and Management of Dermatologic Toxicity Following Enfortumab Vedotin Rechallenge in Patients With Metastatic Urothelial Carcinoma: A Retrospective Single-Center Study.
Authors: Kawahara T; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan., Nagumo Y; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan., Yamaguchi A; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan., Hamada K; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan., Tanuma K; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan., Nitta S; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan., Shiga M; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan., Ikeda A; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan., Kandori S; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan., Hoshi A; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan., Nishiyama H; Department of Urology, Faculty of Medicine, University of Tsukuba, Tsukuba, Ibaraki, Japan.
Source: Cancer reports (Hoboken, N.J.) [Cancer Rep (Hoboken)] 2026 Jan; Vol. 9 (1), pp. e70466.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: John Wiley & Sons, Inc Country of Publication: United States NLM ID: 101747728 Publication Model: Print Cited Medium: Internet ISSN: 2573-8348 (Electronic) Linking ISSN: 25738348 NLM ISO Abbreviation: Cancer Rep (Hoboken) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2573-8348
DOI:10.1002/cnr2.70466